Page last updated: 2024-08-23

piritrexim and Sarcoma 180

piritrexim has been researched along with Sarcoma 180 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bowers, SW; Duch, DS; Edelstein, MP; Nichol, CA	1

Other Studies

1 other study(ies) available for piritrexim and Sarcoma 180

Article	Year
Biochemical and chemotherapeutic studies on 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine (BW 301U), a novel lipid-soluble inhibitor of dihydrofolate reductase. Cancer research, 1982, Volume: 42, Issue:10 Topics: Animals; Antineoplastic Agents; Biological Transport; Carcinoma 256, Walker; Drug Evaluation, Preclinical; Folic Acid Antagonists; Histamine N-Methyltransferase; Humans; Leukemia, Myeloid; Mice; Pyrimidines; Sarcoma 180; Structure-Activity Relationship	1982

Article

Year

Biochemical and chemotherapeutic studies on 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine (BW 301U), a novel lipid-soluble inhibitor of dihydrofolate reductase.

Cancer research, 1982, Volume: 42, Issue:10

Topics: Animals; Antineoplastic Agents; Biological Transport; Carcinoma 256, Walker; Drug Evaluation, Preclinical; Folic Acid Antagonists; Histamine N-Methyltransferase; Humans; Leukemia, Myeloid; Mice; Pyrimidines; Sarcoma 180; Structure-Activity Relationship

1982